230 related articles for article (PubMed ID: 16844446)
21. Neuroendocrine differentiation in prostatic carcinoma: an update.
di Sant'Agnese PA
Prostate Suppl; 1998; 8():74-9. PubMed ID: 9690666
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of proliferation activity and neuroendocrine differentiation to predict treatment failure after radical prostatectomy.
May M; Siegsmund M; Hammermann F; Loy V; Gunia S
Scand J Urol Nephrol; 2007; 41(5):375-81. PubMed ID: 17853019
[TBL] [Abstract][Full Text] [Related]
23. Neuroendocrine differentiation in prostate cancer.
Cerović SJ; Brajusković GR; Vukotić Maletić VD; Mićić SR
Vojnosanit Pregl; 2004; 61(5):513-8. PubMed ID: 15551804
[TBL] [Abstract][Full Text] [Related]
24. Apoptosis resistance of neuroendocrine phenotypes in prostatic adenocarcinoma.
Fixemer T; Remberger K; Bonkhoff H
Prostate; 2002 Oct; 53(2):118-23. PubMed ID: 12242726
[TBL] [Abstract][Full Text] [Related]
25. [Serum chromogranin A in prostate cancer].
Akakura K
Nihon Rinsho; 2002 Dec; 60 Suppl 11():160-4. PubMed ID: 12599564
[No Abstract] [Full Text] [Related]
26. Neuroendocrine differentiation in prostatic intraepithelial neoplasia and adenocarcinoma.
Bostwick DG; Dousa MK; Crawford BG; Wollan PC
Am J Surg Pathol; 1994 Dec; 18(12):1240-6. PubMed ID: 7977947
[TBL] [Abstract][Full Text] [Related]
27. Neuroendocrine differentiation in the progression of prostate cancer.
Komiya A; Suzuki H; Imamoto T; Kamiya N; Nihei N; Naya Y; Ichikawa T; Fuse H
Int J Urol; 2009 Jan; 16(1):37-44. PubMed ID: 19120524
[TBL] [Abstract][Full Text] [Related]
28. Nodal neuroendocrine (Merkel cell) carcinoma without an identifiable primary tumor.
Kuwabara H; Mori H; Uda H; Takei K; Ishibashi Y; Takatani N
Acta Cytol; 2003; 47(3):515-7. PubMed ID: 12789943
[No Abstract] [Full Text] [Related]
29. Paneth cell-like change in prostatic adenocarcinoma represents neuroendocrine differentiation: report of 30 cases.
Adlakha H; Bostwick DG
Hum Pathol; 1994 Feb; 25(2):135-9. PubMed ID: 7509774
[TBL] [Abstract][Full Text] [Related]
30. Prostate epithelial cell differentiation and its relevance to the understanding of prostate cancer therapies.
Long RM; Morrissey C; Fitzpatrick JM; Watson RW
Clin Sci (Lond); 2005 Jan; 108(1):1-11. PubMed ID: 15384949
[TBL] [Abstract][Full Text] [Related]
31. Neuroendocrine differentiation in primary Merkel cell carcinoma--possible prognostic significance.
Koljonen V; Haglund C; Tukiainen E; Böhling T
Anticancer Res; 2005; 25(2A):853-8. PubMed ID: 15868919
[TBL] [Abstract][Full Text] [Related]
32. Cytochemical markers and DNA content of neuroendocrine cells in carcinoma of the prostate gland during tumour progression.
Falkmer S; Askensten U; Grimelius L; Abrahamsson PA
Acta Histochem Suppl; 1990; 38():127-32. PubMed ID: 2080236
[No Abstract] [Full Text] [Related]
33. Unusual prostate carcinoma characterized by extensive metastasis, significantly increased serum level of prostatic-specific antigen,and neuroendocrine differentiation: a case report.
Hu YX; Ye J; Jiang Y; Zhang QF; Wu YL; Chen YY
Chin Med J (Engl); 2005 Feb; 118(3):258-61. PubMed ID: 15740661
[No Abstract] [Full Text] [Related]
34. Endocrine-paracrine cell types in the prostate and prostatic adenocarcinoma are postmitotic cells.
Bonkhoff H; Stein U; Remberger K
Hum Pathol; 1995 Feb; 26(2):167-70. PubMed ID: 7532147
[TBL] [Abstract][Full Text] [Related]
35. NeuroD1 expression in human prostate cancer: can it contribute to neuroendocrine differentiation comprehension?
Cindolo L; Franco R; Cantile M; Schiavo G; Liguori G; Chiodini P; Salzano L; Autorino R; Di Blasi A; Falsaperla M; Feudale E; Botti G; Gallo A; Cillo C
Eur Urol; 2007 Nov; 52(5):1365-73. PubMed ID: 17126478
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of neuroendocrine differentiation in carcinoma of the prostate.
Dema A; Raica M; Tudose N
Rom J Morphol Embryol; 1996; 42(1-2):83-8. PubMed ID: 9038390
[TBL] [Abstract][Full Text] [Related]
37. Clinical implication of neuroendocrine differentiation in prostatic adenocarcinomas.
Constantinides C; Pavlaki K; Zizi D; Gavriel J; Mitropoulos D; Garifalos J; Dimopoulos C
Urol Int; 1995; 55(3):134-6. PubMed ID: 8540155
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical analysis of neuroendocrine differentiation in prostate cancer.
Ishida E; Nakamura M; Shimada K; Tasaki M; Konishi N
Pathobiology; 2009; 76(1):30-8. PubMed ID: 19188748
[TBL] [Abstract][Full Text] [Related]
39. Localization of immunoreactive HIF-1alpha and HIF-2alpha in neuroendocrine cells of both benign and malignant prostate glands.
Monsef N; Helczynski L; Lundwall A; Påhlman S;
Prostate; 2007 Aug; 67(11):1219-29. PubMed ID: 17562539
[TBL] [Abstract][Full Text] [Related]
40. Paraganglion of the prostate gland: an uncommon mimic of prostate cancer in needle biopsies.
Howarth SM; Griffiths DF; Varma M
Histopathology; 2005 Jul; 47(1):114-5. PubMed ID: 15982332
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
